David Gallardo Giralt

Nom:
David Gallardo Giralt
Firma: David Gallardo Giralt
Posició:
Responsable del Grup

Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: resultsfrom a nationwide series of 236 patients

Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.

Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.

Subscriure a David Gallardo Giralt